Search results
Results from the Tech24 Deals Content Network
2024 Medicare Advantage and Part D Star Ratings, U.S. Centers for Medicare and Medicaid Services. Accessed July 22, 2024. Accessed July 22, 2024. About the writer
Post-exposure prophylaxis. Other names. Post-exposure prevention. [ edit on Wikidata] Post-exposure prophylaxis, also known as post-exposure prevention ( PEP ), is any preventive medical treatment started after exposure to a pathogen in order to prevent the infection from occurring. It should be contrasted with pre-exposure prophylaxis, which ...
Ratings are updated yearly, but data is two years old before Medicare releases it. [1] [18] [19] Healthgrades develops objective ratings based on data and information from several publicly available sources. [18] The data is analyzed using a proprietary methodology that identifies the recipients of the various awards and the "1-3-5 Star ...
The cost of Blue Cross Blue Shield Medicare Advantage coverage will vary by your location and the plan type you choose. All Medicare Advantage plans require you to pay the standard premium for ...
The Healthcare Effectiveness Data and Information Set ( HEDIS) is a widely used set of performance measures in the managed care industry, developed and maintained by the National Committee for Quality Assurance (NCQA). HEDIS was designed to allow consumers to compare health plan performance to other plans and to national or regional benchmarks.
(Reuters) - The Centers for Medicare & Medicaid Services said in a memo on Thursday it will recalculate the quality ratings of Medicare Advantage plans for people aged 65 years and above, which ...
Positron emission tomography ( PET) [ 1] is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption. Different tracers are used for various imaging ...
Polyestradiol phosphate (PEP), sold under the brand name Estradurin, is an estrogen medication which is used primarily in the treatment of prostate cancer in men. [1] [9] [2] [10] It is also used in women to treat breast cancer, as a component of hormone therapy to treat low estrogen levels and menopausal symptoms, and as a component of feminizing hormone therapy for transgender women.